These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38978020)

  • 1. Providers and women's perspectives on opportunities, challenges and recommendations to improve cervical cancer screening in women living with HIV at Mbarara Regional Referral Hospital: a qualitative study.
    Agaba CD; Namuli A; Ainomugisha B; Tibaijuka L; Ninsiima M; Ngonzi J; Akatukwasa C; Owaraganise A
    BMC Womens Health; 2024 Jul; 24(1):392. PubMed ID: 38978020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of integration of cervical cancer screening into routine HIV care, associated factors and perceptions among HIV-infected women: a mixed methods study at Mbarara Regional Referral Hospital, Uganda.
    Ninsiima M; Nyabigambo A; Kagaayi J
    BMC Health Serv Res; 2023 Apr; 23(1):333. PubMed ID: 37013535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of HPV screening among HIV-infected women attending an HIV-dedicated clinic in Abidjan, Côte d'Ivoire.
    Mensah K; Assoumou N; Duchesne V; Pourette D; DeBeaudrap P; Dumont A
    BMC Womens Health; 2020 Jul; 20(1):155. PubMed ID: 32723350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the role of embarrassment in gynaecological screening: a qualitative study from the ASPIRE cervical cancer screening project in Uganda.
    Teng FF; Mitchell SM; Sekikubo M; Biryabarema C; Byamugisha JK; Steinberg M; Money DM; Ogilvie GS
    BMJ Open; 2014 Apr; 4(4):e004783. PubMed ID: 24727360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motivations and barriers to cervical cancer screening among HIV infected women in HIV care: a qualitative study.
    Bukirwa A; Mutyoba JN; Mukasa BN; Karamagi Y; Odiit M; Kawuma E; Wanyenze RK
    BMC Womens Health; 2015 Oct; 15():82. PubMed ID: 26458898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.
    Effah K; Anthony R; Tekpor E; Amuah JE; Wormenor CM; Tay G; Kraa SEY; Katso AM; Akonnor CA; Kemawor S; Danyo S; Atuguba BH; Essel NOM; Akakpo PK
    Cancer Control; 2024; 31():10732748241244678. PubMed ID: 38563112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitators and Barriers to HPV Self-Sampling as a Cervical Cancer Screening Option among Women Living with HIV in Rural Uganda.
    Nyabigambo A; Mayega RW; Hlongwana K; Ginindza TG
    Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297609
    [No Abstract]   [Full Text] [Related]  

  • 8. Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity.
    Mitchell SM; Pedersen HN; Eng Stime E; Sekikubo M; Moses E; Mwesigwa D; Biryabarema C; Christilaw J; Byamugisha JK; Money DM; Ogilvie GS
    BMC Womens Health; 2017 Jan; 17(1):4. PubMed ID: 28086933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives of women participating in a cervical cancer screening campaign with community-based HPV self-sampling in rural western Kenya: a qualitative study.
    Oketch SY; Kwena Z; Choi Y; Adewumi K; Moghadassi M; Bukusi EA; Huchko MJ
    BMC Womens Health; 2019 Jun; 19(1):75. PubMed ID: 31196175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of HIV and cervical cancer screening perceptions and preferences of communities in Uganda.
    Kumakech E; Andersson S; Wabinga H; Berggren V
    BMC Womens Health; 2015; 15():23. PubMed ID: 25783655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between HIV Serostatus and premalignant cervical lesions among women attending a cervical cancer screening clinic at a tertiary care facility in southwestern Uganda: a comparative cross-sectional study.
    Kirabira J; Kayondo M; Bawakanya SM; Nsubuga EJ; Yarine F; Namuli A; Namugumya R; Natulinda CH; Atwine R; Birungi A; Lugobe HM; Tibaijuka L; Kisombo D; Jjuuko M; Agaba DC; Saturday P; Atupele SM; Tumusiime M; Migisha R; Kajabwangu R
    BMC Womens Health; 2024 Apr; 24(1):266. PubMed ID: 38678278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "The best thing is that you are doing it for yourself" - perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study.
    Bakiewicz A; Rasch V; Mwaiselage J; Linde DS
    BMC Womens Health; 2020 Mar; 20(1):65. PubMed ID: 32234028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
    Vahabi M; Lofters A
    BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics.
    Di Salvo I; Mnzava D; Nicoletti GJ; Senkoro E; Ndege RC; Huang DJ; Makunja NT; Kassiga GI; Kaufmann AM; Weisser M; Kind AB
    BMC Health Serv Res; 2023 Mar; 23(1):234. PubMed ID: 36894985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's experiences with cervical cancer screening in a colposcopy referral clinic in Cape Town, South Africa: a qualitative analysis.
    Momberg M; Botha MH; Van der Merwe FH; Moodley J
    BMJ Open; 2017 Feb; 7(2):e013914. PubMed ID: 28213603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake and correlates of cervical cancer screening among women attending a community-based multi-disease health campaign in Kenya.
    Choi Y; Ibrahim S; Park LP; Cohen CR; Bukusi EA; Huchko MJ
    BMC Womens Health; 2022 Apr; 22(1):122. PubMed ID: 35436908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing.
    Racey CS; Gesink DC
    J Rural Health; 2016; 32(2):136-45. PubMed ID: 26265118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Collection for HPV Testing: Potential Issues Related to Performance Measures and Quality Improvement Among Federally Qualified Health Centers.
    Le A; Wheeler SB; Lafata JE; Teal R; Giannone K; Smith LS; Zaffino M; Smith JS
    J Public Health Manag Pract; 2024 Sep-Oct 01; 30(5):688-700. PubMed ID: 38985535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
    Nakigozi H; Ndejjo R; Bazeyo W; Nabaggala A; Achola C; Iga M; Kalyesubula S; Kanamwangi B; Mutungi G; Batte C; Mukunya D; Sserwanga L; Gemageine G; Oyoo CA; Nabadda S
    BMC Cancer; 2024 Feb; 24(1):243. PubMed ID: 38383366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge, facilitators and barriers to cervical cancer screening among women in Uganda: a qualitative study.
    Ndejjo R; Mukama T; Kiguli J; Musoke D
    BMJ Open; 2017 Jun; 7(6):e016282. PubMed ID: 28606908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.